18 apr 2018
CPhI Japan 2018
Sai Life Sciences

Sai Life Sciences

Exhibitor at CPhI Japan 2018 stand Q-31

About us

Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025.  It works with innovator pharma and biotech companies across USA, EU & Japan, accelerating the discovery, development and manufacture of complex small molecules. Over the past two decades, Sai Life Sciences has consistently delivered on a diverse set of NCE development programs for its customers with a track record of bringing value based on quality, pricing and responsiveness. Today, as one of India’s fastest growing CDMO companies, Sai Life Sciences works with the leading large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is backed by committed long-term investors, TPG Capital and HBM Healthcare Investments.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Advanced Intermediates |Analytical Chemistry |Analytical Chemistry More

Products featured at CPhI Japan 2018

Sai Life Sciences

Event information

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan Visit us at stand Q-31